CyberLiver Limited

📍 STANMORE, United Kingdom🗓 Founded 2012👥 7 employees
CyberLiver is a late clinical stage Prescription Digital Therapeutics platform for managing and treating Advanced Liver Diseases. We are a pioneer in discovering, developing, and delivering clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement, tracking and management tools for clinicians which are cost-effective and scalable. We lead the fight against advanced liver disease with prescription digital therapies. Two of our products have completed phase 2 equivalent clinical trials, third in discovery phase. 1. AlcoChange® - for the treatment of Alcohol-Related Liver Disease (ARLD) patients 2. CirrhoCare® - for remote monitoring and treatment of decompensated cirrhosis patients For more information, visit us at www.cyberliver.com
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2012
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was CyberLiver Limited founded?
CyberLiver Limited was founded in 2012.
What industry is CyberLiver Limited in?
CyberLiver Limited operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is CyberLiver Limited based?
CyberLiver Limited is headquartered in STANMORE, United Kingdom.